66--BIO-RAD LABORATORIES BPA

Amendment / Modification

This amendment (0001) to solicitation 140G0226Q0014 modifies the original solicitation as follows:

• The solicitation is reopened.

• The small business set-aside has been removed, and the solicitation is now under Full and Open Competition.

• The Period of Performance has been set from 06/01/2026 to 05/31/2031.

• The solicitation number is 140G0226Q0014.

• The effective date of this amendment is 04/24/2026.

• The original solicitation date was 04/24/2026.

• The amendment reopens the solicitation, implying that new offers may be accepted or existing offers may need to be revised.

• The removal of the small business set-aside changes the eligibility requirements for potential offerors.

• The period of performance has been specified as 06/01/2026 to 05/31/2031.

• The overall Not to Exceed (NTE) Value for the Blanket Purchase Agreement (BPA) is $200,000.00 for its life.

• The document describes a Blanket Purchase Agreement (BPA) for Chronic Wasting Disease (CWD), Enzyme Linked Immunosorbent Assay (ELISA) Test Kits.

• The BPA is for non-personal services and requires the contractor to provide plant, equipment, facilities, labor, supervision, and materials.

• The NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing).

• The government is not obligated to place orders, and the contractor is not obligated to accept them. The BPA can be canceled by either party.

Form / Attachment / Pricing Sheet

This document is Attachment B, a Price Schedule, for the solicitation. It outlines the pricing structure for the goods or services required.

• The schedule includes line items for 'Cronic Wasting Desease (CWD) ELISA test kits'.
• Pricing is broken down by Year 1 through Year 5, with a 'Total' column.

Bidders must use this schedule to input their pricing for the specified items over the contract period. This will be a key component of their proposal submission and will likely be used in the evaluation process.

Solicitation / RFP / RFQ

This document is a solicitation for a Blanket Purchase Agreement (BPA) for "Chronic Wasting Disease (CWD), Enzyme Linked Immunosorbent Assay (ELISA) Test Kits." The BPA will be a firm-fixed-price type, with individual BPA Call orders awarded as firm-fixed-price.

• Procurement of "Chronic Wasting Disease (CWD), Enzyme Linked Immunosorbent Assay (ELISA) Test Kits."

• The BPA requires the contractor to provide all plant, equipment, necessary facilities, labor, supervision, and materials to deliver the goods in compliance with the terms and conditions of the BPA and attached specifications.

• Contract Type: Firm-Fixed-Price BPA with firm-fixed-price BPA Call orders.

• Period of Performance: Estimated from 05/01/2026 through 04/30/2031 (5 years).

• Overall Not-to-Exceed Value: $200,000.00 for the life of the BPA.

• Payment Terms: Payments may be made via Government Purchase Card for orders under $10,000.00 or through the Treasury's Invoice Payment Platform (IPP) for orders over $10,000.00 up to $100,000.00.

• Quotation Submission Deadline: April 29, 2026, no later than 5:00 P.M. Eastern time.

• Submission Method: E-mail to yvette_sornberger@ios.doi.gov.

• Basis for Award: Award will be made to the responsible vendor submitting the lowest-priced quote that is determined to be technically acceptable. Tradeoffs will not be made.

• Technical Acceptability: Offerors must provide technical information (brochures or specifications) demonstrating the proposed product meets all minimum requirements.

• Product Requirements: Only authentic, manufacturer-certified products in original packaging will be accepted. No gray-market, counterfeit, or resale items.

• The acquisition is set aside for Small Business (100%).

• NAICS Code: 334516 (Analytical Laboratory Instrument Manufacturing)

• Size Standard: 1,000 employees.

• The BPA is not a contract; an enforceable contract exists only when the Government places a BPA Call order and the Contractor accepts it.

• The Government is not obligated to place BPA Call orders, and the Contractor is not obligated to accept them.

• The following attachments are referenced: Attachment A - Specifications, Attachment B - Price Schedule (Excel Spreadsheet Template).

Form / Attachment / Pricing Sheet

This document, "B08_Attachment_A_Specifications.docx", outlines the technical requirements for NAHLN-compliant Cervid Spongiform Disease (CSD) / Chronic Wasting Disease (CWD) ELISA diagnostic test kits. It details the scope, background, applicable documents, and specific technical requirements for these kits.

• Scope: Requires contractor to provide labor, materials, reagents, and shipping for CSD/CWD ELISA diagnostic test kits.
• Technical Requirements:
  • Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA) for detecting misfolded prion protein (PrP^res) in cervid tissues.
  • Specimen Compatibility: Must be validated for retropharyngeal lymph nodes (RPLN) and obex tissues from white-tailed deer, mule deer, elk, and moose.
  • Performance: Minimum diagnostic sensitivity ≥ 95%, specificity ≥ 98%, repeatability CV < 15%, reproducibility CV < 20%.
  • Kit Components: Must include all necessary reagents for a 96-well plate, positive/negative controls, enzyme conjugate, substrate, wash buffer, stop solution, IFU, and lot-specific Certificate of Analysis.
  • Laboratory Compatibility: Compatible with standard equipment, no proprietary equipment required.
  • Throughput: Support ≥ 90 samples per plate, assay run time ≤ 4 hours.
  • Packaging/Stability: Minimum 6 months shelf life at delivery, store at 2–8°C, ship in insulated containers.
• Quality Assurance: Requires lot-specific Certificates of Analysis, recall notification, and GMP/ISO-compliant quality systems.
• Deliverables: NAHLN-validated kits, IFU, quality documentation, SDS, packing slip.
• Shipping: Temperature-controlled conditions required.
• Warranty: Replacement of defective or non-conforming kits.
• Customer Support: Technical assistance and troubleshooting.

This attachment is critical for potential bidders as it defines the precise technical specifications, performance standards, and deliverable requirements for the CWD/CSD ELISA test kits. Bidders must ensure their proposed products meet or exceed all listed requirements to be considered compliant. It details the expected quality, compatibility, and logistical considerations for the kits.